A Woman comparing Telfast® with another medicine in the allergy aisle at a store, looking approvingly towards Telfast®.

Get the Telfast® Advantage

Do what you want. Go where you want. Any time of year. Live with relief — without without seasonal allergic rhinitis symptoms.

Telfast® is:

 Non-sedating, long-lasting “with 24 hours relief of allergy symptoms”.¹

 Effective relief from multiple symptoms of seasonal allergic rhinitis.1

A happy girl focused on her schoolwork.

And we have formulas for kids (Suspension).¹

Our children’s products are non-sedating.¹That means your kids get relief in school with no impact on their learning or concentration due to sedation.§ Children’s Telfast® 12 hour suspension offers hours of non-sedating relief in a kid-approved white uniform aqueous suspension with a raspberry cream flavor.¹ 

Product shots of Telfast-Decongestant®

Telfast® is here to help

Telfast® 120 mg and 180 mg helps you live better life by relieving many seasonal allergic rhinitis symptoms when taken at the first sign of allergies.¹

View all products

§Starts working in one hour.1
Artificial raspberry cream flavor.1

    1. Telfast Ministry of Health Approved Leaflet, approval date: 29/11/2018.

    2. Cauwenberge V, STAR STUDY INVESTIGATING GROUP. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clinical & Experimental Allergy. 2000 Jun;30(6):891-9.

    3. Meltzer EO, Casale TB, Nathan RA, Thompson AK. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology. 1999 Oct 1;83(4):311-7.

    4. Compalati E, Baena-Cagnani R, Penagos M, Badellino H, Braido F, Gómez RM, Canonica GW, Baena-Cagnani CE. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. International archives of allergy and immunology. 2011;156(1):1-5.

    5.Hampel F, Ratner P, Mansfield L, Meeves S, Liao Y, Georges G. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to severe seasonal allergic rhinitis. Annals of Allergy, Asthma & Immunology. 2003 Oct 1;91(4):354-61.

Approved by Egyptian Drug Authority: HF0253OA300/102022. Invalidation date: 20/10/2023. Kindly report any violated online promotional, educational and awareness material not having this message to The General administration for Regulation of Marketing & Advertising Materials at: www.edaegypt.gov.eg